M. A. Hely

5.4k total citations · 2 hit papers
32 papers, 4.0k citations indexed

About

M. A. Hely is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, M. A. Hely has authored 32 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Physiology. Recurrent topics in M. A. Hely's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (18 papers) and Neurological diseases and metabolism (3 papers). M. A. Hely is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (18 papers) and Neurological diseases and metabolism (3 papers). M. A. Hely collaborates with scholars based in Australia, United States and United Kingdom. M. A. Hely's co-authors include John G. Morris, Wayne G.J. Reid, Glenda M. Halliday, Michael Adena, Peter Williamson, Wisam Reid, R. Traficante, David O’Sullivan, G. Anthony Broe and D J O'Sullivan and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

M. A. Hely

31 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

2008 1.6k citations M. A. Hely, Wayne G.J. Reid et al. Movement Disorders profile →
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

2004 790 citations M. A. Hely, John G. Morris et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. A. Hely Australia	20	3.4k	823	765	652	576	32	4.0k
Wayne G.J. Reid Australia	7	2.4k 0.7×	576 0.7×	614 0.8×	488 0.7×	499 0.9×	10	2.9k
Tien K. Khoo Australia	33	3.1k 0.9×	642 0.8×	736 1.0×	774 1.2×	454 0.8×	69	4.2k
Giovanni Abbruzzese Italy	39	3.7k 1.1×	1.2k 1.5×	729 1.0×	823 1.3×	437 0.8×	98	4.9k
M. B. Stern United States	16	1.9k 0.6×	535 0.7×	603 0.8×	587 0.9×	432 0.8×	20	3.0k
Peter Kempster Australia	27	3.0k 0.9×	772 0.9×	398 0.5×	388 0.6×	440 0.8×	87	3.8k
Marina Picillo Italy	42	4.1k 1.2×	1.1k 1.3×	603 0.8×	991 1.5×	504 0.9×	167	5.2k
Inga Liepelt‐Scarfone Germany	23	2.2k 0.6×	396 0.5×	568 0.7×	503 0.8×	538 0.9×	100	3.0k
Rebecca Stowe United Kingdom	20	4.5k 1.3×	723 0.9×	1.2k 1.5×	988 1.5×	321 0.6×	29	5.5k
Maria Teresa Pellecchia Italy	42	3.5k 1.0×	1.1k 1.3×	488 0.6×	867 1.3×	498 0.9×	173	5.0k
W R Gibb United Kingdom	29	5.2k 1.5×	1.8k 2.2×	823 1.1×	935 1.4×	1.0k 1.8×	61	6.6k

Countries citing papers authored by M. A. Hely

Since Specialization

Citations

This map shows the geographic impact of M. A. Hely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Hely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Hely more than expected).

Fields of papers citing papers by M. A. Hely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Hely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Hely. The network helps show where M. A. Hely may publish in the future.

Co-authorship network of co-authors of M. A. Hely

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Hely. A scholar is included among the top collaborators of M. A. Hely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Hely. M. A. Hely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ralston, David R., et al.. (2024). Creutzfeldt–Jakob disease: From presentation to palliative care. Australian Journal of General Practice. 53(10). 699–702.

Chang, Florence, et al.. (2016). 2. Antecollis associated with Parkinson’s disease improved following apomorphine therapy. Clinical Neurophysiology. 127(3). e10–e11. 2 indexed citations

Reid, Wisam, et al.. (2011). Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). Journal of Neurology Neurosurgery & Psychiatry. 82(9). 1033–1037. 140 indexed citations

Hely, M. A., John G. Morris, Wisam Reid, et al.. (2009). Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurologica Scandinavica. 92(6). 455–463. 39 indexed citations

Hely, M. A., Wayne G.J. Reid, Michael Adena, Glenda M. Halliday, & John G. Morris. (2008). The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Movement Disorders. 23(6). 837–844. 1614 indexed citations breakdown →

Halliday, Glenda M., M. A. Hely, Wayne G.J. Reid, & John G. Morris. (2008). The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathologica. 115(4). 409–415. 300 indexed citations

Huang, Yue, Mike Hayes, Antony J. Harding, et al.. (2006). Anticipation of onset age in familial Parkinson's disease without SCA gene mutations. Parkinsonism & Related Disorders. 12(5). 309–313. 3 indexed citations

Hely, M. A., et al.. (2004). Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years. Movement Disorders. 20(2). 190–199. 790 indexed citations breakdown →

Koller, William C., et al.. (2001). Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations. Movement Disorders. 16(5). 858–866. 60 indexed citations

10.

Henderson, J. M., et al.. (2001). Parkinson's disease with late Pick's dementia. Movement Disorders. 16(2). 311–319. 8 indexed citations

11.

Hely, M. A., Victor S.C. Fung, & John G. Morris. (2000). Treatment of Parkinson's disease. Journal of Clinical Neuroscience. 7(6). 484–494. 21 indexed citations

12.

Hely, M. A., et al.. (1999). The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. Journal of Neurology Neurosurgery & Psychiatry. 67(3). 300–307. 290 indexed citations

13.

Halliday, Glenda M., D.A. McRitchie, Heidi Cartwright, et al.. (1996). Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. Journal of Clinical Neuroscience. 3(1). 52–60. 82 indexed citations

14.

Hely, M. A. & John G. Morris. (1996). Controversies in the treatment of Parkinsonʼs disease. Current Opinion in Neurology. 9(4). 308–313. 6 indexed citations

15.

Hely, M. A., et al.. (1996). A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia. Journal of Clinical Neuroscience. 3(4). 327–333. 63 indexed citations

16.

Hely, M. A., et al.. (1996). An Australian multicentre open label study of pergolide as an adjunct to levodopa in Parkinson's disease. Journal of Clinical Neuroscience. 3(3). 234–238. 6 indexed citations

17.

Hely, M. A., Tien Chey, Andrew Wilson, et al.. (1993). Reliability of the columbia scale for assessing signs of parkinson's disease. Movement Disorders. 8(4). 466–472. 43 indexed citations

18.

Hely, M. A., et al.. (1991). Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy. Internal Medicine Journal. 21(s1). 82–84. 4 indexed citations

19.

Reid, Wisam, G. Anthony Broe, M. A. Hely, et al.. (1989). The Neuropsychology of de Novo Patients with Idiopathic Parkinson's Disease: The Effects of Age of Onset. International Journal of Neuroscience. 48(3-4). 205–217. 66 indexed citations

20.

Hely, M. A., John G. Morris, David Rail, et al.. (1989). The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.. Journal of Neurology Neurosurgery & Psychiatry. 52(3). 324–328. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact